Solara Active Pharma Sciences posts consolidated Q2 FY2024 loss at Rs. 17.16 Cr
Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023
Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023
Krsnaa Diagnostics Limited has operationalized one diagnostics center at district hospital Male Akbarpur, Kanpur Dehat, Uttar Pradesh.
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
Ranitidine Hydrochloride is an important product for Solara and is manufactured at its Cuddalore site
The merger is in line with Solara’s strategy of accelerating growth via appropriate inorganic actions
Subscribe To Our Newsletter & Stay Updated